Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC)

Clinical and Translational Oncology

Volumn 12, Issue 12, 2010, Pages 829-835

  Cedrés, Susana ^a   Quispe, Isela ^a   Martínez, Pablo ^a   Longo, Marina ^a   Rodríguez, Eva ^a   Serrano, César ^a   Muñoz, Eva ^a   Pallisa, Esther ^a   Felip, Enriqueta ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Non small cell lung cancer; Prognostic factors; Stage i; Tumour size

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84875046405     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-010-0605-6     Document Type: Review

References (40)

1. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
2. Chansky K, Sculier JP, Crowley JJ et al (2009) The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 4:792-801.
3. Martini N, Bains MS, Burt ME et al (1995) Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109:120.
4. Mountain CF (1997) Revisions in the International System for Staging Lung Cancer. Chest 111:1710-1717. (Pubitemid 27260107)
5. Hoffman PC, Mauer AM, Vokes EE (2000) Lung cancer. Lancet 355:479-485 [Erratum, Lancet 2000;355:12]. (Pubitemid 30085163)
6. Sobin LH, Wittekind Ch (eds) (2002) TNM classifi cation of malignant tumours, 6th Edn. Wiley, New York.
7. Groome PA, Bolejack V, Crowley J et al (2007) The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classifi cation of malignant tumours. J Thorac Oncol 2:694-705. (Pubitemid 47357521)
8. Kawai H, Tada A, Kawahara M et al (2005) The Japan National Hospital Study Group for Lung Cancer. Smoking history before surgery and prognosis in patients with stage IA non small cell lung cancer - a multicenter study. Lung Cancer 49:63-70. (Pubitemid 40798094)
9. Nordquist LT, Simon GR, Cantor A et al (2004) Improved survival in never-smokers versus current smokers with primary adenocarcinoma of the lung. Chest 126:347-351. (Pubitemid 39093415)
10. Moro-Silot D, Aubert A, Diab S et al (2005) Comorbidities and Charlson score in resected stage I non-small cell lung cancer. Eur Respir J 26:480-486. (Pubitemid 41264213)
11. Berardi R, Brunelli A, Tamburrano T et al (2005) Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancer. Lung Cancer 49:371-376. (Pubitemid 41139150)
12. Berghmans T, Dusart M, Paesmans M et al (2008) Primary tumor standarized uptake value (SUV max) measured on fluordeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-anaysis by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 3:6-12.
13. Gail MH, Eagan RT, Feld R et al (1984) Prognostic factors in patients with resected satge I nonsmall cell lung cancer. A report from the Lung Cancer Study Group. Cancer 54:1802-1813.
14. Lipford EH 3rd, Eggleston JC, Lillemoe KD et al (1984) Prognostic factors in surgically resected limited-stage, non-small cell carcinoma of the lung. Am J Surg Pathol 8:357-365. (Pubitemid 14148460)
15. Cagini L, Monacelli M, Giustozzi G et al (2000) Biological prognostic factors for early stage completely resected non-small cell lung cancer. J Surg Oncol 74:53-60. (Pubitemid 30387224)
16. Takise A, Kodama T, Shimosato Y et al (1988) Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer 61:2083-2088.
17. Kwiatkowski DJ, Harpole DH Jr, Godleski J et al (1998) Molecular pathologic substaging in 244 stage I non-small cell lung cancer patients: clinical implications. J Clin Oncol 16:2468-2477. (Pubitemid 28309043)
18. Raponi M, Zhang Y, Yu J et al (2006) Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 66:7466-7472. (Pubitemid 44289200)
19. Raz DJ, Ray MR, Kim JY et al (2008) A multigene assay is prognostic of survival in patients with early stage lung adenocarcinoma. Clin Cancer Res 14:5565-5570.
20. Potti A, MukherjeeS, Peterson R et al (2007) A five-gene signature and clinical outcome in non- small cell lung cancer. N Engl J Med 356: 11-20.
21. Skrzypski M, Jassem E, Mendez P et al (2007) Expression profile of 29 genes by real-time quantitative PCR (RT-QPCR) in early-stage (I-IIIA) squamous cell carcinoma of the lung (SCCL). J Clin Oncol 25[Suppl]:abstract 7612.
22. Tsao MS, Zhu C, Ding K et al (2008) A 15-gene expression signature prognostic for survival and predictive for adjuvant chemotherapy benefit in JBR.10 patients. J Clin Oncol 26[Suppl]:abstract 7510.
23. Olaussen KA, Dunant A, Fouret P et al (2006) DNA repair by ERCC1 in non-small cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355:983-991. (Pubitemid 44343542)
24. Weatherall M, Marsh S, Shirtcliffe P et al (2009) Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J 33:1025-1030.
25. Strauss GM, Herndon JE, Maddaus MA et al (2008) Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 26:5043-5051.
26. Burdett S, Stewart LA, Rydzewska L (2006) A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer. J Thorac Oncol 1:611-621. (Pubitemid 47163946)
27. Lardinois D, Weder R, Hany TF (2003) Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500-2507. (Pubitemid 36706537)
28. Toloza EM, Harpole L, McCrory DC (2003) Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123:137S-146S. (Pubitemid 36135711)
29. Birim O, Kappetein AP, Stijnen T et al (2005) Meta-analyses of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg 79:375-381.
30. Kelly RF, Tran T, Holmstrom A et al (2004) Accuracy and cost-effectiveness of [18F]-2-fl uorodeoxy- D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer. Chest 125:1413-1423. (Pubitemid 38501358)
31. Hoekstra CJ, Stroobandts SG, Hoekstra OS et al (2003) The value of [18F]-2-fluoro-deoxy- D-glucose-positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment. Lung Cancer 39:151-157. (Pubitemid 36173615)
32. Fischer B, Lassen U, Mortensen J et al (2009) Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 361:32.
33. Halpern BS, Schiepers C, Weber WA et al (2005) Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 128:2289-2297. (Pubitemid 41507571)
34. Viney RC, Boyer MJ, King MT et al (2004) Randomized-controlled trial of the role positron emission tomography in the management of stage I and II non-small cell lung cancer. J Clin Oncol 22:2357-2362. (Pubitemid 41115392)
35. Port JL, Andrade RS, Levin MA et al (2005) Positron emission tomographic scanning in the diagnosis and staging of nonsmall cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg 130:1611-1615. (Pubitemid 41676926)
36. Cerfolio RJ, Bryant AS, Ojha B, Eloubeidi M (2005) Improving the inaccuracies of clinical staging of patients with NSCLC. A prospective trial. Ann Thorac Surg 80:1207-1214. (Pubitemid 41354091)
37. D'Cunha J, Herndon JE II, Herzan DL et al (2005) Poor correspondence between clinical and pathologic staging in stage I non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer 48:241-246.
38. Stiles BM, Servais EL, Lee PC et al (2009) Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging. J Thorac Cardiovasc Surg 137:13-19.
39. Hoang T, Xu R, Schiller JH et al (2005) Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third generation chemotherapy regimens based on Eastern Cooperative Oncology Group data. J Clin Oncol 23:175-183. (Pubitemid 41702636)
40. Stanley K (1980) Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 65:25-32. (Pubitemid 10071592)